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BRIEF TECHNIQUE REPORTSLate erosion of an Amplatzer septal occluder device 6 years after
placementNathaniel W. Taggart, MD,a Joseph A. Dearani, MD,b and Donald J. Hagler, MD,a Rochester, MinnCardiac perforation is a rare complication after transcath-
eter closure of an atrial septal defect (ASD) or patent fora-
men ovale (PFO). Erosion usually occurs within the first
days after device placement. We report a case of device
erosion 6 years after device closure of a PFO.CLINICAL SUMMARY
A 46-year-old man underwent transcatheter closure of
a PFO at our institution after a stroke-like event. The
stretched diameter of the PFO was 9 to 10 mm. A 14-mm
Amplatzer septal occluder device (AGA Medical Corpora-
tion, Golden Valley, Minn) was placed. Immediately after
placement, a trivial degree of left-to-right shunt was seen
through the center of the device by intracardiac echocardiog-
raphy; agitated saline injection revealed a trivial right-to-left
shunt. The procedure was uncomplicated, and the patient
was dismissed from the hospital the following day. Predis-
missal transthoracic echocardiogram (TTE) showed good
position and stability of the device with no apparent shunt.
Ten days later, the patient returned with intermittent palpi-
tations. Electrocardiogram revealed atrial fibrillation with
rapid ventricular response. He was given intravenous diltia-
zem and promptly returned to sinus rhythm. TTE again docu-
mentedgoodposition of the occluder devicewith no recurrent
atrial shunt or pericardial effusion. He was observed in the
hospital overnight and dismissed on a regimen of oral diltia-
zem for 1 month. He had no recurrence of atrial fibrillation.
Six years later, he came to the emergency department with
progressive pleuritic chest pain. He had had similar chest
pains 1month prior, which were not extensively investigated,
but resolved spontaneously. In the emergency department he
was hypotensive with mild jugular venous distention. TTE
documented moderate pericardial effusion with tamponade.
Pericardiocentesis removed 325 mL of bloody fluid. Transe-
sophageal echocardiography did not show any evidence of
shunt around the device. The device was again noted to not
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The Journal of Thoracic and Caimaging was unable to document erosion of the occluder de-
vice through the atrialwall or aorta, but in retrospect it did not
appear properly aligned with the superior limbus of septum
secundum (Figure 1).
Hemopericardium recurred, and urgent mediastinal ex-
ploration was performed. Blood, clot, and fibrinous material
were evacuated from the pericardial space. The left atrial
disk of the occluder device was noted to have eroded
through the dome of the left atrium, with approximately 4
to 5 mm of the disk visible from outside the left atrium
(Figure 2). Intermittent, active bleeding was noted exter-
nally at the site of left atrial erosion. After initiation of
cardiopulmonary bypass and administration of cardioplegic
solution, the right atrium was opened and the device was ex-
cised. The atrial septum was repaired with bovine pericar-
dium and the left atrial erosion defect was debrided and
sutured closed. He was dismissed 5 days later but was read-
mitted 12 days later with a sternal wound infection that re-
sponded to debridement and intravenous antibiotic therapy.
DISCUSSION
Erosion is a rare but serious risk of closure of ASDs and
PFOs using Amplatzer septal occluder devices. The rate of
erosion of Amplatzer ASD and PFO occluder devices is esti-
mated to be approximately 0.1% but carries a high risk of
mortality.1,2 Erosion most often occurs at the anterosuperior
wall of the right or left atrium, resulting in pericardial
effusion, frequently with cardiac tamponade. Erosion may
involve the ascending aorta, which may result in a fistulous
atrial–aortic communication and associated heart failure.FIGURE 1. Short-axis view of the atrial septum showing malalignment of
the septal occluder device (arrow) with the superior limbus of the fossa
ovalis. RA, Right atrium; LA, left atrium; Ao, aorta; L, limbus.
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FIGURE 2. Intraoperative photograph of the left atrial disk of the septal
occluder device (arrows) as it protrudes through the dome of the left atrium.
Brief Technique ReportsThe risk of erosion into the aorta has prompted
recommendation against device oversizing and straddling
over the aortic root.2 This recommendation has since been
disputed by expert opinion regarding the mechanism of
device-related erosions.3 Thus, opinions of some experienced
operators concerning erosions by the Amplatzer septal oc-
cluder have been at odds with manufacturer recommenda-
tions.4 This reported left atrial wall erosion may have
resulted from migration of the device through the superior
rim of the atrial septum and through the dome of the left
atrium. This speculation raises questions of unique individual
susceptibility to device erosion through the atrial wall.COMMEN
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222 The Journal of Thoracic and Cardiovascular SurgMost reported cases of erosion occur within 72 hours of
device placement.1,2 The latest reported erosion after PFO
closure occurred 16 months after device placement.5
Erosion after ASD closure has been documented 3 years
after device placement.2
We present the latest known case of device erosion after
placement of a relatively small (14 mm) Amplatzer septal
occluder device, 6 years after placement. This case illus-
trates the importance of recognizing the ongoing, albeit
low, risk of device erosion long after initial ASD/PFO clo-
sure. A history of ASD/PFO device closure should prompt
appropriate investigation in patients who have chest pain,
shortness of breath, new-onset heart failure symptoms, or
other symptoms suggestive of a cardiac etiology.References
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Thorac Surg. 2006;81:e29-30.TARYContinued controversy regarding adverse events after Amplatzer septal
device closure: Mass hysteria or tip of the iceberg?Daniel J. DiBardino, MD,a and John E. Mayer, Jr, MDbIn this issue of the Journal, Taggart and coauthors1 have re-
ported their experiencewith late erosion of anAmplatzer sep-
tal occluder device (AGA Medical Corporation, Plymouth,Minn), resulting in cardiac tamponade and necessitating sub-
sequent emergency surgery.1 Findings at surgery were perfo-
ration of the left side of the disk through the dome of the left
atrium. This case report contains several interesting pieces of
history including arrhythmia 10 days after Amplatzer device
placement and chest pain 1 month before the patient’s subse-
quent presentation with tamponade. They point out that 6
years is longer than the hazard function for erosion is com-
monly thought to have still been in effect. The longest previ-
ously reported interval between insertion and erosion of an
Amplatzer devicewas 3 years. It seems that the complication
pattern of this device is still being defined.ery c July 2011
